Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Search Results for "IGA":

Results: 362

Quotes

IGA Voya Global Advantage & Premium Opportunity Fund Stock - NYSE equities IGAC IG Acquisition Corp Stock - NASDAQ equities BETZ Roundhill Sports Betting & iGaming ETF ETF - NYSE etf IGACU IG Acquisition Corp Stock - NASDAQ equities IGACW IG Acquisition Corp Stock - NASDAQ equities IGAS Indraprastha Gas Ltd Stock - NSE equities IGAM Igarashi Motors India Ltd Stock - NSE equities IGASc1:NS Indraprastha Gas Ltd Future Stock Future - NSE equities
Show all (22)

News

Voya Investment declares quarterly distribution on Funds
By Seeking Alpha

Voya Asia Pacific High Dividend Equity Income Fund (NYSE:IGA) - $0.225. Voya Natural Resources Equity Income Fund (NYSE:IRR) - $0.162. Payable Oct. 15; for shareholders of record Oct. 2;...

Indonesia stocks higher at close of trade; IDX Composite Index up 0.03%
By Investing.com

Investing.com – Indonesia stocks were higher after the close on Monday, as gains in the Mining sectors led shares higher. At the close in Jakarta, the IDX Composite Index added 0.03%. The best...

Indonesia stocks lower at close of trade; IDX Composite Index down 0.44%
By Investing.com

Investing.com – Indonesia stocks were lower after the close on Monday, as losses in the Mining sectors led shares lower. At the close in Jakarta, the IDX Composite Index lost 0.44%. The best...

Show all (252)

Analysis

Scientific Games, Everi Holdings Announce IGaming Alliance
By Zacks Investment Research

Scientific Games (NASDAQ:PRFT) , each sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.The long-term earnings growth rate for ManTech...

Incyte Down As FDA Extends Review Period Of Jakafi For GVHD
By Zacks Investment Research

Shares of Incyte Corporation (NASDAQ:LLY) and Incyte Corporation announced positive top-line data from two late-stage studies, evaluating their oral JAK inhibitor, Olumiant (baricitinib) as...

Aduro (ADRO) Q1 Earnings And Revenues Fall Shy Of Estimates
By Zacks Investment Research

Aduro BioTech, Inc. (NASDAQ:BMY) Yervoy (ipilimumab) for the treatment of relapsed/refractory melanoma.Earlier, ADU-S100 was being investigated as a single agent. However, the protocol was amended...

Show all (88)
Results: 22

Refine Results

Instrument Type

Region

 

Country

Exchange

Sector

 

Industry

 
Results: 252

Refine Results

Date

Date
 

Category

Provider

 

News

{{title}}
By {{provider}}

{{content}}

Please try another search

Results: 88

Refine Results

Date

Date
 

Category

Author

Analysis

{{title}}
By {{provider}}

{{content}}

Results: 0

Refine Results

Country

Importance

Economic Events

Results: 0

Tools & Sections

Results: 0

Authors

Continue with Google
or
Sign up with Email